- Portfolio Prep for Next Week: 'Don't Get Crazy'
- Strategists on Dubai: Avoid 'Rash Moves' Now
- Dubai Stock Market Fear Has 'Legs': Dennis Gartman
- Surprising Options Trades in TiVo Shares
- 10 Dividend Picks For Your Portfolio: Chief Investors
- 4 Thanksgiving Week Buys For Your Portfolio: Market Pros
- There's a 'Great Chance' For a Double-Dip Recession: Strategist
- Retail Earnings and Sales to Improve in Q4: Analyst
- 4 Food Stocks to Stuff in Your Portfolio: Analyst
- S&P at 1050-1200 Trading Range Next Year: Strategist
- U.S. Stocks Fall on Dubai Worries
- Black Friday at Best Buy
- Strategists on Dubai: Avoid 'Rash Moves' Now
- Longer Lines, Fuller Carts This Black Friday
- Dubai Stock Market Fear Has 'Legs': Dennis Gartman
- Obama's Emission Reduction Pledge Paints Future for Autos
- Is Super Bowl Halftime Act Too Old?
- Surprising Options Trades in TiVo Shares
- EA Sports Hopes to Pump Up Sales Through Pop-Up Locations
- Dubai's Debt Woes Signal New Era for Creditors
- US Treasury Wants Banks to Do More to Ease Mortgages
- Fed Audit Would Hurt Economic Prospects: Bernanke
- Next Week: Cash In Now Or Wait For A Santa Rally?
- Dubai Stock Selloff May Bring Buying Opportunity
- Black Friday Sales Rise by 0.5%: ShopperTrak
- Longer Lines, Fuller Carts This Black Friday
- Big US Banks May Be Forced to Raise Capital: Bove
- Bank of America Amends Pay for Senior Executives
RSS FEED
CNBC Stock Blog
Traders are aggressively buying calls in Omnicare ahead of its earnings report Thursday morning.
Shares of the geriatric pharmaceutical services company are falling today along with the broader markets, but its March calls are trading higher. The buying is focused on the March 30 calls, which traded more than 5,000 contracts this morning mostly for $1.05, according to OptionMonster's tracking systems.
OCR stock [OCR
Loading...
()
] is down some 5 percent in midday trading to just under $27. It has been on a roller-coaster ride since its highs over $32 in September to lows under $20 in October, but the stock has been solid recently as the company declared a quarterly cash dividend earlier this month.
___________________________________
Other Pharma Benefits Managers:
CVS Caremark [CVS
Loading...
()
]
MedcoHealth Solutions [MHS
Loading...
()
]
Express Scripts [ESRX
Loading...
()
]
___________________________________
Pete Najarian is a professional investor, CNBC contributor, regular co-host of CNBC's "Fast Money" and co-founder of OptionMonster.com.
___________________________________








